| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |